Co-Diagnostics, Inc. to Attend AACC 2017

SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, will be sending Company representatives on August 2-3, 2017, to attend the 69th AACC...